1-12 of 12
particle size
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Wholegrain Particle Size Influences Postprandial Glycemia in Type 2 Diabetes: A Randomized Crossover Study Comparing Four Wholegrain Breads

Andrew N. Reynolds, Jim Mann, Mona Elbalshy, Evelyn Mete, Caleb Robinson, Indrawati Oey, Pat Silcock, Nerida Downes, Tracy Perry, Lisa Te Morenga
Journal: Diabetes Care
Diabetes Care 2020;43(2):476–479
https://doi.org/10.2337/dc19-1466
Published: 13 January 2020
View article titled, Wholegrain Particle Size Influences Postprandial Glycemia in Type 2 Diabetes: A Randomized Crossover Study Comparing Four Wholegrain Breads
Open the PDF for Wholegrain Particle Size Influences Postprandial Glycemia in Type 2 Diabetes: A Randomized Crossover Study Comparing Four Wholegrain Breads in another window
Includes: Supplementary data
Journal Articles

Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis

Rachel H. Mackey, Samia Mora, Alain G. Bertoni, Christina L. Wassel, Mercedes R. Carnethon, Christopher T. Sibley, David C. Goff, Jr.
Journal: Diabetes Care
Diabetes Care 2015;38(4):628–636
https://doi.org/10.2337/dc14-0645
Published: 15 January 2015
View article titled, Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis
Open the PDF for Lipoprotein Particles and Incident Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis in another window
Includes: Supplementary data
Journal Articles

Adiponectin and Lipoprotein Particle Size

Ram Weiss, MD, PHD, James D. Otvos, PHD, Allan Flyvbjerg, MD, DMSC, Andre R. Miserez, MD, Jan Frystyk, MD, PHD, Ronit Sinnreich, PHD, Jeremy D. Kark, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1317–1319
https://doi.org/10.2337/dc09-0084
Published: 23 April 2009
View article titled, Adiponectin and Lipoprotein Particle Size
Open the PDF for Adiponectin and Lipoprotein Particle Size in another window
Journal Articles

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

Mark A. Deeg, MD, John B. Buse, MD, Ronald B. Goldberg, MD, David M. Kendall, MD, Anthony J. Zagar, MS, Scott J. Jacober, DO, Mehmood A. Khan, MD, Alfonzo T. Perez, MD, Meng H. Tan, MD, on behalf of the GLAI Study Investigators
Journal: Diabetes Care
Diabetes Care 2007;30(10):2458–2464
https://doi.org/10.2337/dc06-1903
Published: 01 October 2007
View article titled, Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia
Open the PDF for Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia in another window
Journal Articles

Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients

Richard J. Woodman, MMedSci, Trevor A. Mori, PHD, Valerie Burke, MD, Ian B. Puddey, MD, Gerald F. Watts, MD, PHD, James D. Best, MD, Lawrence J. Beilin, MD
Journal: Diabetes Care
Diabetes Care 2003;26(1):253
https://doi.org/10.2337/diacare.26.1.253
Published: 01 January 2003
View article titled, Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients
Open the PDF for Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients in another window
Journal Articles

Deterioration of the Metabolic Risk Profile in Women: Respective contributions of impaired glucose tolerance and visceral fat accumulation

Agnés Pascot, MSC, Jean-Pierre Després, PHD, Isabelle Lemieux, MSC, Natalie Alméras, PHD, Jean Bergeron, MD, MSC, André Nadeau, MD, Denis Prud’homme, MD, MSC, Angelo Tremblay, PHD, Simone Lemieux, PHD
Journal: Diabetes Care
Diabetes Care 2001;24(5):902–908
https://doi.org/10.2337/diacare.24.5.902
Published: 01 May 2001
View article titled, Deterioration of the Metabolic Risk Profile in Women: <subtitle>Respective contributions of impaired glucose tolerance and visceral fat accumulation </subtitle>
Open the PDF for Deterioration of the Metabolic Risk Profile in Women: <subtitle>Respective contributions of impaired glucose tolerance and visceral fat accumulation </subtitle> in another window
Meeting Abstracts

Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.

R Boizel, P Y Benhamou, B Lardy, F Laporte, T Foulon, S Halimi
Journal: Diabetes Care
Diabetes Care 2000;23(11):1679–1685
https://doi.org/10.2337/diacare.23.11.1679
Published: 01 November 2000
View article titled, Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
Open the PDF for Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. in another window
Meeting Abstracts

LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.

A Festa, R D'Agostino, Jr, L Mykkänen, R P Tracy, C N Hales, B V Howard, S M Haffner
Journal: Diabetes Care
Diabetes Care 1999;22(10):1688–1693
https://doi.org/10.2337/diacare.22.10.1688
Published: 01 October 1999
View article titled, LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
Open the PDF for LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study. in another window
Meeting Abstracts

Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.

H Matsui, K Okumura, Y Toki, T Hayakawa
Journal: Diabetes Care
Diabetes Care 1999;22(7):1220–1221
https://doi.org/10.2337/diacare.22.7.1220a
Published: 01 July 1999
View article titled, Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level.
Open the PDF for Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. in another window
Journal Articles

Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins

Jacques Massé, MD, MSC, FRCPC
Journal: Diabetes Care
Diabetes Care 1995;18(8):1199–1200
https://doi.org/10.2337/diacare.18.8.1199b
Published: 01 August 1995
View article titled, Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins
Open the PDF for Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins in another window
Journal Articles

Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins, Obesity, ana Insulin Resistance in Japanese Men

Tadashi Suehiro, MD, Takashi Ohguro, MD, Ryota Sumiyoshi, MD, Nobukazu Yasuoka, MD, Yuh Nakauchi, MD, Yoshitaka Kumon, MD, Kozo Hashimoto, MD
Journal: Diabetes Care
Diabetes Care 1995;18(3):333–338
https://doi.org/10.2337/diacare.18.3.333
Published: 01 March 1995
View article titled, Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins, Obesity, ana Insulin Resistance in Japanese Men
Open the PDF for Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins, Obesity, ana Insulin Resistance in Japanese Men in another window
Journal Articles

Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes

Sanni Lahdenperä, MD, Marju Tilly-Kiesi, MD, Helena Vuorinen-Markkola, MD, Timo Kuusi, MD, Marja-Riitta Taskinen, MD
Journal: Diabetes Care
Diabetes Care 1993;16(4):584–592
https://doi.org/10.2337/diacare.16.4.584
Published: 01 April 1993
View article titled, Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes
Open the PDF for Effects of Gemfibrozil on Low-Density Lipoprotein Particle Size, Density Distribution, and Composition in Patients With Type II Diabetes in another window